Cystic Fibrosis Foundation Appoints Marc Ginsky as Chief Operating Officer

The Cystic Fibrosis Foundation announced the appointment of Marc Ginsky as executive vice president and chief operating officer. Mr. Ginsky will oversee the Foundation's day-to-day operations with a focus on field management, information technology and the Foundation's infrastructure.

| 4 min read

BETHESDA, Md., May 2, 2016 -- The Cystic Fibrosis Foundation announced the appointment of Marc Ginsky as executive vice president and chief operating officer. Mr. Ginsky will oversee the Foundation's day-to-day operations with a focus on field management, information technology and the Foundation's infrastructure. He will report to and work alongside Dr. Preston W. Campbell, III, president and chief executive officer, to advance the Foundation's mission to cure cystic fibrosis and help people with the disease live longer, healthier lives.  

“We're thrilled to welcome Marc to our team and have him join us in our fight against cystic fibrosis,” said Dr. Campbell. “Marc brings significant expertise in health care with almost two decades of experience and will be an extremely valuable addition to our team. He shares a passion for our mission and will make major contributions across the organization, helping to ensure that serving people with CF and their families is at the heart of everything we do.”  

Mr. Ginsky brings more than 18 years of experience from the health care industry, with a focus on expanding patient access to life-changing treatments. He joins the Foundation from Covance -- a leading contract research organization supporting clinical trials and market access needs of its clients. He served as the vice president and general manager of the Market Access Services division since 2007. In this role, he helped lead a business that developed and managed patient support programs for pharmaceutical and biotechnology companies, as well as provided health economics consulting support to these organizations. Prior to that, he worked in Covance's legal department in roles of increasing responsibility from 1998 to 2006, supporting all aspects of the drug development and market access businesses of the company. Before joining Covance, Marc was a corporate attorney in private practice for 10 years.

“I'm honored to become part of the CF Foundation -- an organization that has had an unmatched impact on the lives of people with CF and their families,” said Ginsky. “I have been so impressed by the progress that has been made in the fight against cystic fibrosis, thanks to the Foundation's efforts, and the deep connections the organization has with its supporters. I'm eager to put my background to good use on behalf of people with CF and the entire CF community.”

Mr. Ginsky earned an MBA from New York University's Leonard N. Stern School of Business and a J.D. from the University of Pennsylvania Law School. He completed his undergraduate studies in accounting and finance at the SUNY at Buffalo School of Management.

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation funds more cystic fibrosis research than any other organization, and nearly every CF drug available today was made possible because of Foundation support. Based in Bethesda, Md., the Foundation also supports and accredits a national care center network that has been recognized by the National Institutes of Health as a model of care for a chronic disease. The Cystic Fibrosis Foundation is a donor-supported nonprofit organization. For more information, go to  www.cff.org.

Share this article
Topics
About the CF Foundation
Recent news
Cystic Fibrosis Foundation Strikes First-of-Its-Kind Deal With Pioneering Medicines, a Flagship Pioneering Initiative
News | 4 min read
CF Foundation Strongly Urges Universal Masking in Schools
News | 2 min read
CF Foundation Launches Lung Transplant Biorepository and Patient Registry
News | 4 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe